WuXi AppTec (HKG:2359, SHA:603259) disposed of a further 50.8 million shares, equivalent to a 4.23% stake, in WuXi XDC Cayman (HKG:2268) for around HK$2.18 billion on Tuesday, a Wednesday filing with the Hong Kong bourse said.
The drug research and development company previously sold 86 million shares in the target company for roughly HK$2.43 billion on Nov. 8, 2024, and Jan. 10, 2025.
The firm will use proceeds from the sale to accelerate the construction of global production capacity and capability, attract and retain outstanding talent, and strengthen its unique integrated CRDMO business model.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.